AJIC: American Journal of Infection Control
Volume 36, Issue 10 , Pages 711-717 , December 2008

A comparison of infection control program resources, activities, and antibiotic resistant organism rates in Canadian acute care hospitals in 1999 and 2005: Pre- and post-severe acute respiratory syndrome

  • Dick E. Zoutman, MD, FRCPC

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dick E. Zoutman, MD, FRCPC, Department of Pathology and Molecular Medicine, Queen's University and Infection Control Service, Kingston General Hospital, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada.
    • ,
  • B. Douglas Ford, MA

References 

  1. Zoutman DE, Ford BD, Bryce E, Gourdeau M, Herbert G, Henderson E, et al. The state of infection surveillance and control in Canadian acute care hospitals. Am J Infect Control. 2003;31:266–272
  2. Zoutman DE, Ford BD Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada. The relationship between hospital infection surveillance and control activities and antibiotic resistant pathogen rates. Am J Infect Control. 2005;33:1–5
  3. Macias AE, Ponce-de-Leon S. Infection control: old problems and new challenges. Arch Med Res. 2005;36:637–645
  4. Shaw K. The 2003 SARS outbreak and its impact on infection control practices. Public Health. 2006;120:8–14
  5. Goldrick BA, Goetz AM. Pandemic influenza: what infection control professionals should know. Am J Infect Control. 2007;35:7–13
  6. Blair RC, Taylor RA. Biostatistics for the health sciences. Upper Saddle River, NJ: Pearson Prentice Hall; 2008;
  7. Commission to Investigate the Introduction and Spread of Severe Acute Respiratory Syndrome (SARS). The SARS Commission. 2006. Available at: http://www.sarscommission.ca/index.html. Accessed February 14, 2008.
  8. Ontario Expert Panel on SARS and Infectious Disease Control. Final Report of the Ontario Expert Panel on SARS and Infectious Disease Control. 2004. Available at: http://www.health.gov.on.ca/english/public/pub/ministry_reports/walker04/walker04_mn.html. Accessed February 14, 2008.
  9. The Standing Senate Committee on Social Affairs, Science and Technology. Reforming health protection and promotion in Canada: time to act. 2003. Available at: http://www.parl.gc.ca/37/2/parlbus/commbus/senate/Com-e/SOCI-E/rep-e/repfinnov03-e.htm#_ftnref3. Accessed February 14, 2008.
  10. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173:1037–1042
  11. Eggertson L. Quebec strikes committee on Clostridium difficile. CMAJ. 2004;171:123
  12. Pindera L. C difficile inquest too narrow as “Quebec strain” goes international. CMAJ. 2007;167:915–916
  13. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874–885
  14. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–1771
  15. Kuijper EJ, Coignard B, Tüll P ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl 6):2–18
  16. Simor AE, Ofner-Agostini M, Gravel D, Varia M, Paton S, McGeer A, et al. Canadian Nosocomial Infection Surveillance Program (CNISP) Surveillance for Methicillin-Resistant Staphylococcus aureus in Canadian hospitals—a report update from the Canadian Nosocomial Infection Surveillance Program. Can Commun Dis Rep. 2005;31:1–7http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/dr3103ea.htmlAvailable at: Accessed February 14, 2008
  17. Ofner-Agostini M, Johnston BL, Simor AE, Embil J, Matlow A, Mulvey M, et al. Canadian Nosocomial Infection Surveillance Program Vancomycin-resistant Enterococci in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2005. Infect Control Hosp Epidemiol. 2008;29:271–274
  18. O'Boyle C, Jackson M, Henly SJ. Staffing requirements for infection control programs in US health care facilities: Delphi project. Am J Infect Control. 2002;30:321–333
  19. Health Canada, Division of Occupational and Nosocomial Infections. Development of a resource model for infection prevention and control programs in acute, long-term, and home care settings: conference proceedings of the Infection Prevention and Control Alliance. Am J Infect Control. 2004;32:2–6
  20. Scheckler WE, Brimhall D, Buck AS, Farr BM, Friedman C, Garibaldi RA, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Am J Infect Control. 1998;26:47–60
  21. Farr B. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir. Infect Control Hosp Epidemiol. 2006;27:1096–1106

 Conflicts of interest: The authors report no conflicts of interest.

PII: S0196-6553(08)00554-3

doi: 10.1016/j.ajic.2008.02.008

AJIC: American Journal of Infection Control
Volume 36, Issue 10 , Pages 711-717 , December 2008

Article Tools